Annotated Medicine and Device Lists
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alfacalcidol | Capsule | 1 mcg | |
| alfacalcidol | Tablet | 0.25 mcg | |
| alfaelosulfase | Solution for injection | 5 mg | |
| alfataliglicerase | Powder for injection | 200 U | |
| alfavelaglicerase | Powder for injection | 200 U | |
| alfavelaglicerase | Powder for injection | 400 U | |
| aluminum hydroxide | Oral suspension | 61.5 mg/ ml | |
| aluminum hydroxide | Tablet | 230 mg | |
| aluminum hydroxide | Tablet | 300 mg | |
| atropine | Solution for injection | 0,25 mg/ ml | |
| biotin | Capsule | 2,5 mg | |
| calcitriol | Capsule | 0.25 mcg | |
| calcitriol | Injection | 1 mcg/ml | |
| calcium carbonate | Tablet | 1.250 mg | |
| calcium carbonate + colecalciferol | Tablet | 1.250 mg/ 200 UI | |
| calcium carbonate + colecalciferol | Tablet | 1.250 mg/ 400 UI | |
| calcium carbonate + colecalciferol | Tablet | 1.500 mg/ 400 UI | |
| calcium fosfato + colecalciferol | Tablet | 600 mg/ 400 UI | |
| carbon activado | N/A | N/A | |
| chlorhexidine | Solution for mouth rinse | 0.12 % | |
| galsulfasa | Solution for injection | 5 mg/ml | |
| glibenclamide | Tablet | 5 mg | |
| gliclazide | Tablet | 80 mg | |
| gliclazide | Tablet (prolonged release) | 30 mg | |
| gliclazide | Tablet (prolonged release) | 60 mg | |
| glycerol | Suppository | 72 mg | |
| glycerol | Suspension | 120 mg/ ml | |
| idursulfasa | Solution for injection | 2 mg/ ml | |
| imiglucerasa | Solution for injection | 200 U | |
| imiglucerasa | Solution for injection | 400 U | |
| lactulose | Syrup | 667 mg/ ml | |
| laronidasa | Solution for injection | 0.58 mg/ ml | |
| magnesium sulfate | Injection | 10% | |
| magnesium sulfate | Injection | 50% | |
| magnesium sulfate | Oral solution | N/A | |
| mesalazine | enema | 10 mg/ ml | |
| mesalazine | enema | 30 mg/ ml | |
| mesalazine | Suppository | 1000 mg | |
| mesalazine | Suppository | 250 mg | |
| mesalazine | Suppository | 500 mg | |
| mesalazine | Tablet | 400 mg | |
| mesalazine | Tablet | 800 mg | |
| mesalazine | Tablet (prolonged release) | 500 mg | |
| metformin | Tablet | 500 mg (hydrochloride) | |
| metformin | Tablet | 850 mg (hydrochloride) | |
| metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
| metoclopramide | Oral liquid | 4 mg (hydrochloride)/mL | |
| metoclopramide | Tablet | 10 mg (hydrochloride) | |
| miconazole | Gel | 2% (20 mg/ g) | |
| miglustate | Capsule | 100 mg | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| omeprazole | Capsule | 10 mg | |
| omeprazole | Capsule | 100 000 UI | |
| omeprazole | Capsule | 20 mg | |
| ondansetron | comprimido orodispersivel | 4 mg | |
| ondansetron | comprimido orodispersivel | 8 mg | |
| ondansetron | Tablet | 4 mg | |
| ondansetron | Tablet | 8 mg (chlorohydrate) | |
| oral rehydration salts | Oral solution | N/A | |
| pancreatin | Capsule | 10 000 U | |
| pancreatin | Capsule | 25000 U | |
| pyridoxine | Tablet | 100 mg | |
| pyridoxine | Tablet | 40 mg | |
| ranitidine | Injection | 25 mg/ml (hydrochloride) | |
| ranitidine | Syrup | 15 mg/ ml | |
| ranitidine | Tablet | 150 mg | |
| retinol | Capsule | 200 000 IU (as palmitate) | |
| retinol | Oral solution | 150 000 UI/ ml | |
| sapropterina | Tablet | 100 mg | |
| sulfasalazine | Tablet | 500 mg | |
| tiamina | Tablet | 300 mg | |
| trientine | Capsule | 250 mg | |
| ursodeoxycholic acid | Tablet | 150 mg | |
| ursodeoxycholic acid | Tablet | 300 mg | |
| ursodeoxycholic acid | Tablet | 50 mg | |
| zinc sulfate | Solution for injection | 200 mcg/ ml | |
| zinc sulfate | Syrup | 4 mg/ ml | |
| zinc sulfate | Tablet (chewable) | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abciximab | Solution for injection | 2 mg/ ml | |
| acetato de sodium | Solution for injection | 2 mEq/ ml | |
| acetylsalicylic acid | Tablet | 100 mg | |
| albumin | Solution for injection | 0.2 g/ ml (20%) | |
| alteplase | Injection | 50mg | |
| alteplase | Solution for injection | 10 mg | |
| alteplase | Solution for injection | 20 mg | |
| chloruro de sodio | Solution for injection | 0.9 % | |
| chloruro de sodio | Solution for injection | 3.4 mEq/ ml | |
| clopidogrel | Tablet | 75 mg | |
| cloruro de potasio | Solution for injection | 2.5 mEq/ ml | |
| cloruro de potasio | Solution for injection | 3.4 mEq/ ml | |
| cyanocobalamin | Injection | 1000 mcg/ml | |
| eltrombopag | Tablet | 25 mg | |
| eltrombopag | Tablet | 50 mg | |
| enoxaparin | Injection | 40 mg/ 0.4 ml | |
| epoetin alpha | Injection | 2000 IU/ml in 1ml vial | |
| epoetin alpha | Injection | 4000 IU/ml in 1ml vial | |
| epoetin alpha | Solution for injection | 1 000 UI | |
| epoetin alpha | Solution for injection | 10 000 UI | |
| epoetin alpha | Solution for injection | 3 000 UI | |
| factor IX | Powder for injection | 200 UI a 250 UI | |
| factor IX | Powder for injection | 500 UI a 600 UI | |
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Powder for injection | 1000 UI | |
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Powder for injection | 250 UI | |
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Powder for injection | 2500 UI | |
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Powder for injection | 500 UI | |
| factor IX complex (coagulation factors, II, VII, IX, X) concentrate | Solution for injection | 500 UI a 600 UI | |
| factor VII | Powder for solution | 1 mg | |
| factor VII | Solution for injection | 2 mg | |
| factor VII | Solution for injection | 5 mg | |
| factor VIII | Solution for injection | 1000 UI | |
| factor VIII | Solution for injection | 250 UI | |
| factor VIII | Solution for injection | 500 UI | |
| factor VIII concentrate | Dried | 250 IU | |
| factor VIII concentrate | Dried | 500 IU | |
| factor VIII concentrate | Injection | 1000 UI | |
| factor VIII concentrate | Powder for injection | 450 UI a 500 UI | |
| factor VIII recombinant | Solution for injection | 1000 UI | |
| factor VIII recombinant | Solution for injection | 250 UI | |
| factor VIII recombinant | Solution for injection | 500 UI | |
| factor XIII | Powder for injection | 250 UI | |
| ferrous sulfate | Oral solution | 25 mg/ ml | |
| ferrous sulfate | Syrup | 5 mg/ ml | |
| ferrous sulfate | Tablet | 40 mg | |
| fibrinogeno humano | Powder for injection | 1 g | |
| folic acid | Oral solution | 0,2 mg/ ml | |
| folic acid | Tablet | 5 mg | |
| fosfato de potasio monobasico + dibasico | Solution for injection | 0.03 g/ ml / 0.1567 g/ ml | |
| heparin sodium | Solution for injection | 5 000 UI/ 0.25 ml | |
| iloprost | Solution for inhalation | 0.010 mg | |
| iron | Injection | 20 mg (sacarate)/ml | |
| ringer lactate solution | N/A | N/A | |
| selante de fibrina | Powder | N/A | |
| sodium bicarbonate | Solution for injection | 1 mEq/ ml (8,4 %) | |
| streptokinase | Powder for injection | 250,000 IU | |
| tenecteplase | Powder for injection | 30 mg | |
| tenecteplase | Powder for injection | 40 mg | |
| tenecteplase | Powder for injection | 50 mg | |
| tirofiban | Injection | 0.25mg/ml | |
| tranexamic acid | Tablet | 250mg | |
| tranexamic acid | Tablet | 500 mg | |
| warfarin | Tablet | 1 mg (sodium salt) | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ambrisentana | Tablet | 10 mg | |
| ambrisentana | Tablet | 5 mg | |
| amiodarone | Injection | 50 mg/ml | |
| amiodarone | Tablet | 200 mg | |
| amlodipine | Tablet | 10 mg | |
| amlodipine | Tablet | 5 mg | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| atorvastatine | Tablet | 10 mg | |
| atorvastatine | Tablet | 20 mg | |
| atorvastatine | Tablet | 40 mg | |
| atorvastatine | Tablet | 80 mg | |
| bezafibrato | Tablet | 200 mg | |
| bezafibrato | Tablet (prolonged release) | 400 mg | |
| bosentan | Tablet | 125 mg | |
| bosentan | Tablet | 62.5 mg | |
| captopril | Tablet | 25 mg | |
| captopril | Tablet | 3.125 mg | |
| carvedilol | Tablet | 12.5 mg | |
| carvedilol | Tablet | 25 mg | |
| carvedilol | Tablet | 6.25 mg | |
| ciprofibrato | Capsule | 100 mg | |
| ciprofibrato | Tablet | 20 mg | |
| digoxin | eli | 0.05 mg/ml | |
| digoxin | Tablet | 0.25 mg | |
| dobutamine | Injection | 12.5 mg | |
| dopamine | Solution for injection | 5 mg/ ml | |
| doxazosina | Tablet | 2 mg | |
| doxazosina | Tablet | 4 mg | |
| enalapril | Tablet | 10 mg (maleate) | |
| enalapril | Tablet | 20 mg (maleate) | |
| enalapril | Tablet | 5 mg (as hydrogen maleate) | |
| epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
| etofibrato | Capsule | 500 mg | |
| fenofibrato | Tablet | 200 mg | |
| fenofibrato | Tablet (prolonged release) | 250 mg | |
| fluvastatina | Capsule | 20 mg | |
| fluvastatina | Capsule | 40 mg | |
| furosemide | Injection | 10 mg/ml | |
| furosemide | Tablet | 40 mg | |
| gemfibrozil | Tablet | 600mg | |
| gemfibrozil | Tablet | 900 mg | |
| hydralazine | Tablet | 25 mg | |
| hydralazine | Tablet | 50 mg | |
| hydrochlorothiazide | Tablet | 12.5 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
| isosorbide mononitrate | Tablet | 20mg | |
| isosorbide mononitrate | Tablet | 40 mg | |
| lidocaine | Injection | 2% (hydrochloride) with preservant in 20 mL vial | |
| lidocaine | Solution for injection | 1% 10 mg/ ml | |
| losartan | Tablet | 50mg (potassium) | |
| lovastatin | Tablet | 10 mg | |
| lovastatin | Tablet | 20mg | |
| lovastatin | Tablet | 4o mg | |
| methyldopa | Tablet | 250 mg | |
| metoprolol | Tablet | 100mg (tartrate) | |
| metoprolol | Tablet (prolonged release) | 100 mg (succinato) | |
| metoprolol | Tablet (prolonged release) | 25 mg (succinato) | |
| metoprolol | Tablet (prolonged release) | 50 mg (succinato) | |
| nicotinic acid | Tablet (prolonged release) | 250 mg | |
| nicotinic acid | Tablet (prolonged release) | 500 mg | |
| nicotinic acid | Tablet (prolonged release) | 750 mg | |
| norepinephrine | Solution for injection | 2 mg/ ml | |
| pentoxifylline | Tablet | 400 mg | |
| pravastatin | Tablet | 10mg | |
| pravastatin | Tablet | 20mg | |
| pravastatin | Tablet | 40 mg | |
| propafenone | Tablet | 150 mg | |
| propafenone | Tablet | 300 mg | |
| propranolol | Tablet | 10 mg | |
| propranolol | Tablet | 40mg | |
| sildenafil | Tablet | 25 mg | |
| sildenafil | Tablet | 50 mg | |
| simvastatin | Tablet | 10 mg | |
| simvastatin | Tablet | 20 mg | |
| simvastatin | Tablet | 40 mg | |
| spironolactone | Tablet | 100mg | |
| spironolactone | Tablet | 25 mg | |
| verapamil | Injection | 2.5 mg/mL | |
| verapamil | Tablet | 120 mg | |
| verapamil | Tablet | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Cream | 50 mg/ g (5%) | |
| acido salicilico | Ointment | 50 mg/ g (5%) | |
| acitretin | Capsule | 10 mg | |
| acitretin | Tablet | 25mg | |
| alquitran mineral | Ointment | 10 mg/ g (1 %) | |
| benzoyl peroxide | Gel | 25 mg/ g | |
| benzoyl peroxide | Gel | 50 mg/ g | |
| calcipotriol | Ointment | 50 mcg/g | |
| chlorhexidine | Solution | 2% a 4% | |
| clindamycin | Gel | 1% | |
| clindamycin | Solution | 1% | |
| clobetasol | Cream | 0.5 mg/g | |
| dexamethasone | Cream | 1 mg/ g (0.1 %) | |
| ethyl alcohol (ethanol) | Gel | 70 % | |
| ethyl alcohol (ethanol) | Solution | 70% | |
| hydrocortisone | Cream | 10 mg/ g (1%) | |
| imiquimod | Cream | 50 mg/ g | |
| isotretinoin | Capsule | 10 mg. | |
| isotretinoin | Capsule | 20 mg | |
| ketoconazole | shampoo | 2% | |
| lidocaine | Gel | 2% | |
| miconazole | Cream | 20 mg | |
| miconazole | Lotion | 2% (20 mg/ g) | |
| miconazole | Powder | 2 % (20 mg/ g) | |
| mineral | oil | N/A | |
| podofilotoxina | Cream | 1.5 mg/g | |
| podophyllum resin | Solution | 10% to 25% | |
| potassium permanganate | Powder | 100 mg | |
| potassium permanganate | Tablet | 100 mg | |
| silver sulfadiazine | Cream | 1% | |
| zinc oxide | Cream | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cabergoline | Tablet | 0.5 mg | |
| ciproterone | Tablet | 50 mg (acetate) | |
| conjugated estrogens | Tablet | 0.3 mg | |
| conjugated estrogens | Vaginal cream | 0.625 mg | |
| copper-containing device | N/A | T 380 mm2 | |
| danazol | Capsule | 100 mg | |
| danazol | Capsule | 200 mg | |
| estradiol + norethisterone acetate | Solution for injection | 5 mg/ 50 mg/ ml | |
| estriol | Cream | 1 mg/ g | |
| ethinylestradiol + levonorgestrel | Tablet | 0.03 mg/ 0.15 mg | |
| finasteride | Tablet | 5mg | |
| levonorgestrel | Tablet | 1.5 mg | |
| levonorgestrel | Tablet | 750 micrograms (pack of two) | |
| medroxyprogesterone | suspension inyectable | 150 mg/g | |
| medroxyprogesterone | suspension inyectable | 50 mg/ml | |
| medroxyprogesterone acetate | Tablet | 10 mg | |
| metronidazole | Gel | 100 mg/ g (10%) | |
| miconazole | Cream | 2% (nitrate) | |
| misoprostol | Vaginal tablet | 200 mcg | |
| misoprostol | Vaginal tablet | 25 mcg | |
| nifedipine | Capsule | 10 mg | |
| nifedipine | Tablet | 10 mg | |
| norethisterone | Tablet | 0.35 mg | |
| raloxifeno | Tablet | 60 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone phosfate + betamethasone acetate | Solution nasal | 0.1 mg/ ml | |
| betamethasone phosfate + betamethasone acetate | suspension inyectable | 3 mg/ml/ 3 mg/ml | |
| calcitonina | Nasal spray | 200 UI/ dose | |
| calcitonina | Solution for injection | 50 UI | |
| calcitonina | suspension inyectable | 100 UI | |
| cinacalcet | Tablet | 30 mg | |
| cinacalcet | Tablet | 60 mg | |
| desmopressin | Injection | 15 mcg (acetate)/mL | |
| desmopressin | Solution for injection | 4 mcg/ml (acetate) | |
| desmopressin | Tablet | 0.1 mg | |
| desmopressin | Tablet | 0.2 mg | |
| dexamethasone | eli | 0.1 mg/ml | |
| dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
| dexamethasone | Tablet | 4 mg | |
| fludrocortisone | Tablet | 0.1 mg | |
| hydrocortisone | Injection | 100 mg | |
| hydrocortisone | suspension inyectable | 500 mg | |
| lanreotido | Solution | 60 mg | |
| lanreotido | Solution for injection | 120 mg | |
| lanreotido | Solution for injection | 90 mg | |
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 25 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) | |
| methylprednisolone | Powder for injection | 500 mg (succinate) in vial | |
| octreotide | Powder for injection | 10 mg | |
| octreotide | Powder for injection | 20 mg | |
| octreotide | Powder for injection | 30 mg | |
| octreotide | Solution for injection | 0.1 mg/mL - 1mL | |
| paricalcitol | Solution for injection | 5 mcg/ ml | |
| potassium iodide + iodine | Solution | 20 mg/ml + 40 mg/ ml | |
| prednisolone | Oral solution | 1 mg/ ml | |
| prednisolone | Oral solution | 3 mg/ ml | |
| prednisone | Tablet | 20 mg | |
| prednisone | Tablet | 5 mg | |
| propylthiouracil | Powder for injection | 4 UI | |
| propylthiouracil | Tablet | 100 mg | |
| somatropina | Solution for injection | 12 UI | |
| somatropina | Solution for injection | 15 UI | |
| somatropina | Solution for injection | 16 UI | |
| somatropina | Solution for injection | 18 UI | |
| somatropina | Solution for injection | 24 UI | |
| somatropina | Solution for injection | 30 UI |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abacavir (ABC) | Oral liquid | 20mg/ml | |
| abacavir (ABC) | Tablet | 300 mg | |
| aciclovir | Injection | 250 mg | |
| aciclovir | Tablet | 200 mg | |
| amikacin | Injection | 250 mg/ml | |
| amoxicillin | Capsule | 500 mg | |
| amoxicillin | Oral suspension | 50 mg/ml | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Oral suspension | 50 mg/ml / 12.5 mg/ ml | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| amphotericin B | Injection | 50 mg | |
| amphotericin B | suspension inyectable | 5 mg/ ml | |
| anti rabies human serum | Powder for injection | N/A | |
| anti rabies human serum | Solution for injection | 150 UI/ ml | |
| anti rabies human serum | Solution for injection | 200 UI/ ml | |
| anti-D immunoglobulin (human) | Injection | N/A | |
| anti-D immunoglobulin (human) | Powder for injection | 0.5 g | |
| anti-D immunoglobulin (human) | Powder for injection | 1 g | |
| anti-D immunoglobulin (human) | Powder for injection | 2.5 g | |
| anti-D immunoglobulin (human) | Powder for injection | 3 g | |
| anti-D immunoglobulin (human) | Powder for injection | 5 g | |
| anti-D immunoglobulin (human) | Powder for injection | 6 g | |
| anti-D immunoglobulin (human) | Solution for injection | 0.5 g | |
| anti-D immunoglobulin (human) | Solution for injection | 1 g | |
| anti-D immunoglobulin (human) | Solution for injection | 2.5 g | |
| anti-D immunoglobulin (human) | Solution for injection | 250 mg | |
| anti-D immunoglobulin (human) | Solution for injection | 3 g | |
| anti-D immunoglobulin (human) | Solution for injection | 320 mg | |
| anti-D immunoglobulin (human) | Solution for injection | 5 g | |
| anti-hepatitis B immunoglobulin | Injection | 200 UI/ ml | |
| anti-hepatitis B immunoglobulin | Solution for injection | 100 UI | |
| anti-hepatitis B immunoglobulin | Solution for injection | 180 UI - 200 UI | |
| anti-hepatitis B immunoglobulin | Solution for injection | 500 UI | |
| anti-hepatitis B immunoglobulin | Solution for injection | 600 UI | |
| antibothropic serum | Injection | N/A | |
| antibothropic serum + anticrotalico | Solution for injection | 5 mg/ ml / 1.5 mg/ ml | |
| antibothropic serum + anticrotalico | Solution for injection | 5 mg/ ml / 3 mg/ ml | |
| anticrothalic serum | Injection | N/A | |
| antifidic serum monovalente bothropico | Injectable solution | N/A | |
| antiloxoscelic serum | Injection | N/A | |
| antiloxoscelic serum | Injection | N/A | |
| antitetanus immunoglobulin (human) | Solution for injection | 1000 UI | |
| antitetanus immunoglobulin (human) | Solution for injection | 250 UI/ ml | |
| atazanavir | Capsule | 200 mg | |
| atazanavir | Capsule | 300 mg | |
| azithromycin | Powder for injection | 40 mg/ ml | |
| azithromycin | Tablet | 250 mg | |
| azithromycin | Tablet | 500 mg | |
| BCG vaccine | Powder for injection | multidose | |
| benzathine benzylpenicillin | Powder for injection | 1 200 000 UI | |
| benzathine benzylpenicillin | Powder for injection | 600 000 UI | |
| benzathine benzylpenicillin | suspension inyectable | 1 200 000 UI | |
| benzathine benzylpenicillin | suspension inyectable | 600 000 UI | |
| botulinum toxin A | Solution for injection | 375 UI/ ml / 275 UI/ ml | |
| capreomycin | Powder for injection | 1 g (as sulfate) in vial | |
| cefalexin | Capsule | 500 mg | |
| cefalexin | Oral suspension | 50 mg/ ml | |
| cefalexin | Tablet | 500 mg | |
| cefotaxime | Powder for injection | 250 mg | |
| cefotaxime | Powder for injection | 500 mg | |
| ceftriaxone | Powder for injection | 1g | |
| ceftriaxone | Powder for injection | 500 mg | |
| chloramphenicol | Capsule | 250 mg | |
| chloramphenicol | Oral suspension | 25 mg/ ml | |
| chloramphenicol | Tablet | 250 mg | |
| cholera vaccine | Oral suspension | N/A | |
| ciprofloxacin | Tablet | 250 mg | |
| ciprofloxacin | Tablet | 500 mg | |
| clarithromycin | Capsule | 500 mg | |
| clarithromycin | Oral suspension | 50 mg/ ml | |
| clarithromycin | Tablet | 250mg | |
| clarithromycin | Tablet | 500 mg | |
| clindamycin | Capsule | 150 mg | |
| clindamycin | Capsule | 300 mg | |
| clindamycin | Injection | 150 mg (as phosphate)/mL | |
| clofazimine | Capsule | 100 mg | |
| clofazimine | Capsule | 50 mg | |
| daclatasvir | Capsule | 30 mg | |
| daclatasvir | Capsule | 60 mg | |
| dapsone | Tablet | 100 mg | |
| dapsone | Tablet | 50 mg | |
| darunavir | Tablet | 150 mg | |
| darunavir | Tablet | 300 mg | |
| darunavir | Tablet | 600 mg | |
| darunavir | Tablet | 75 mg | |
| didanosine (ddI) | Powder for oral administration | 4g | |
| diphtheria, tetanus toxoid | Injection | N/A | |
| diphtheria, tetanus toxoid | Injection | N/A | c2 |
| diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
| dolutegravir | Tablet | 50 mg | |
| doxycycline | Powder for injection | 100 mg | |
| doxycycline | Tablet | 100mg | |
| DTP + Hepatitis B + influenzae type B combination vaccine | suspension inyectable | N/A | |
| DTP vaccine | Injection | N/A | |
| DTP vaccine | Injection | N/A | c2 |
| efavirenz (EFV or EFZ) | Capsule | 200 mg | |
| efavirenz (EFV or EFZ) | Oral solution | 30 mg/ml | |
| efavirenz (EFV or EFZ) | Tablet | 600 mg | |
| emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
| enfuvirtida | Solution for injection | 108 mg | |
| entecavir | Tablet | 0.5 mg | |
| entecavir | Tablet | 1 mg | |
| erythromycin | Oral suspension | 25 mg/ ml | |
| erythromycin | Oral suspension | 50 mg/ ml | |
| erythromycin | Tablet | 500 mg (as ethylsuccinate) | |
| estavudina | Oral solution | 1 mg/ ml | |
| ethambutol | Tablet | 400mg | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethionamide | Tablet | 250 mg | |
| etravirine | Tablet | 100 mg | |
| etravirine | Tablet | 200 mg | |
| fluconazole | Capsule | 100 mg | |
| fluconazole | Capsule | 150 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Oral suspension | 10 mg/ ml | |
| fosamprenavir | Oral suspension | 50 mg/ ml | |
| haemophilus influenzae type b vaccine (Hib vaccine) | Powder for injection | N/A | |
| hepatitis A vaccine | suspension inyectable | N/A | |
| hepatitis A vaccine | suspension inyectable | N/A | c2 |
| Immunoglobulin Varicela Zoster | Solution for injection | 125 UI/ 2.5 ml | |
| isoniazid | Tablet | 100mg | |
| isoniazid | Tablet | 300mg | |
| isoniazid + pyrazinamide + rifampicin | Tablet (dispersible) | 50 mg + 150 mg + 75mg | |
| isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
| isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
| isoniazid + rifampicin | Tablet (dispersible) | 50 mg + 75 mg. | |
| itraconazole | Capsule | 100 mg | |
| itraconazole | Oral solution | 10 mg/ ml | |
| lamivudine (3TC) | Oral liquid | 10mg/ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| levofloxacin | Tablet | 250 mg | |
| levofloxacin | Tablet | 500 mg | |
| linezolid | injection for intravenous administration | 2 mg/ ml | |
| linezolid | Tablet | 600 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 100 mg + 25 mg | |
| lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
| maraviroc | Tablet | 150 mg | |
| metronidazole | Tablet | 250 mg | |
| metronidazole | Tablet | 400 mg | |
| minociclina | Tablet | 100 mg | |
| moxifloxacin | Tablet | 400 mg | |
| nevirapine (NVP) | Oral suspension | 10 mg/ ml | |
| nevirapine (NVP) | Tablet | 200 mg | |
| nitrofurantoin | Capsule | 100 mg | |
| nitrofurantoin | Oral suspension | 5 mg/ ml | |
| ofloxacin | Tablet | 400 mg | |
| oseltamivir | Capsule | 30 mg (as phosphate) | |
| oseltamivir | Capsule | 45 mg (as phosphate) | |
| oseltamivir | Capsule | 75 mg (as phosphate) | |
| p-aminosalicylic acid | Granules | 4 g in sachet | |
| palivizumab | Solution for injection | 100 mg | |
| palivizumab | Solution for injection | 50 mg | |
| penicilliamine fenoximetilica (y sales) | Powder for oral administration | 80 000 UI/ ml | |
| pneumococcal vaccine | suspension inyectable | N/A | |
| pneumococcal vaccine -23 | Solution for injection | N/A | |
| pneumococcal vaccine 10 valente | suspension inyectable | N/A | |
| pneumococcal vaccine 13 valente | suspension inyectable | N/A | |
| potassium benzylpenicillin | Powder for injection | 5,000,000 IU | |
| procaine benzylpenicillin + potassium benzylpenicillin | Powder for injection | 300000 UI / 100000 UI | |
| pyrazinamide | Oral liquid | 30 mg/ml | |
| pyrazinamide | Tablet | 500 mg | |
| pyrazinamide | Tablet (dispersible) | 150 mg | |
| raltegavir | Tablet | 100 mg | |
| raltegavir | Tablet | 400 mg | |
| ribavirin | Capsule | 250 mg | |
| rifabutin | Capsule | 150 mg | |
| rifampicin | Capsule | 150 mg | |
| rifampicin | Capsule | 300 mg | |
| rifampicin | Oral liquid | 20 mg/ml | |
| ritonavir | Oral liquid | 80 mg/ml | |
| ritonavir | Tablet (heat stable) | 100 mg | |
| rotavirus vaccine | Suspension | N/A | |
| saquinavir (SQV) | Capsule (softgel) | 200 mg | |
| serum antiescorpionico | Solution for injection | 1.5 DMM/ ml | |
| serum antilonomico | Solution for injection | 0.35 mg/ ml | |
| sofosbuvir | Tablet | 400 mg | |
| spiramycin | Tablet | 500 mg | |
| streptomycin | Powder for injection | 1 g | |
| sulfadiazine | Tablet | 500 mg | |
| sulfamethoxazole + trimethoprim | Oral suspension | 40 mg/ml / 8 mg/ ml | |
| sulfamethoxazole + trimethoprim | Solution for injection | 80 mg/ml / 16 mg/ ml | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| tenofovir + lamivudine | Tablet | 300/ 300 mg | |
| tenofovir disoproxil fumarate | Tablet | 300 mg | |
| tenofovir disoproxilo + efavirenz + lamivudine | Tablet | 300 mg/ 600 mg/ 300 mg | |
| terizidona | Capsule | 250 mg | |
| tetracycline | Capsule | 500 mg | |
| tipranavir | Capsule | 250 mg | |
| tipranavir | Oral solution | 100 mg/ ml | |
| tobramycin | Solution for inhalation | 300 mg | |
| trivalent anti-influenza vaccine | suspension inyectable | N/A | |
| vacuna antimeningococcica conjugada | Solution for injection | N/A | |
| vacuna antipoliomelitica atenuada | Oral solution | N/A | |
| vacuna antipoliomelitica inactivada | suspension inyectable | N/A | |
| vacuna antitifoidica inactivada | Solution for injection | N/A | |
| vacuna contra virus papiloma humano | suspension inyectable | N/A | |
| vacuna sarampion, papaeras, rubeola y varicela | Powder for injection | Norma PAI | |
| vacuna triple viral (Sarampion, rubeola y parotiditis) | Powder for injection | N/A | |
| varicella vaccine | Powder for injection | N/A | |
| yellow fever vaccine | Powder for injection | N/A | |
| zanamivir | Powder | 5 mg | |
| zidovudine (ZDV or AZT) | Capsule | 100 mg | |
| zidovudine (ZDV or AZT) | Injection | 10 mg/mL | |
| zidovudine (ZDV or AZT) | Suspension | 10 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abatacept | Powder for injection | 250 mg | |
| abatacept | Solution for injection | 125 mg | |
| adalimumab | Solution for injection | 40 mg | |
| anti-human thymocyte immunoglobulin (equine) | Powder for injection | 100 mg | |
| azathioprine | Tablet | 50 mg | |
| basiliximab | Powder for injection | 20 mg | |
| CD3 monoclonal antibody | Intravenous administration | 5 mg in 5 mL vial | |
| certolizumab pegol | Solution for injection | 200 mg/ ml | |
| ciclosporin | Capsule (softgel) | 10 mg | |
| ciclosporin | Capsule (softgel) | 100 mg | |
| ciclosporin | Capsule (softgel) | 25 mg | |
| ciclosporin | Capsule (softgel) | 50 mg | |
| ciclosporin | Solution | 100 mg/ml | |
| ciclosporin | Solution for injection | 50 mg | |
| cyclophosphamide | Tablet | 50 mg | |
| daclizumab | Solution for injection | 5 mg/ ml | |
| eculizumabe | Solution for dilution | 10 mg/ml | |
| etanercept | Injection | 25 mg | |
| etanercept | Injection | 50 mg | |
| everolimus | Tablet | 0.5 mg | |
| everolimus | Tablet | 0.75 mg | |
| everolimus | Tablet | 1 mg | |
| filgrastim | Injection | 300 mcg/ml | |
| fingolimod | Capsule | 0.5 mg | |
| glatiramero acetato | Solution for injection | 20 mg | |
| glatiramero acetato | Solution for injection | 40 mg | |
| golimumab | Solution for injection | 50 mg | |
| golimumab | Solution for injection | 50 mg | |
| goserelin | implant | 10.8 mg | |
| goserelin | implant | 3.6 mg | |
| hydroxyurea | Capsule | 500 mg | |
| immunoglobulin antitimocitos humanos | Powder for injection | 100 mg | |
| immunoglobulin antitimocitos humanos | Powder for injection | 200 mg | |
| infliximab | Injection | 100 mg | |
| interferon alpha 2B | Powder for injection | 10 000 000 UI | |
| interferon alpha 2B | Powder for injection | 3 000 000 UI | |
| interferon alpha 2B | Powder for injection | 5 000 000 UI | |
| interferon beta 1A | Solution for injection | 22 ug (6 millones U.I/ 0.5 mL) | |
| interferon beta 1A | Solution for injection | 30 ug (6 millones U.I/ 0.5 mL) | |
| interferon beta 1A | Solution for injection | 44 mcg (12 millones UI) | |
| interferon beta 1B | Powder for injection | 300 mcg /9.6 millones UI) | |
| leflunomide | Tablet | 20 mg | |
| leuprorelin (leuprolide acetate) | Injection | 11.25 MG | |
| leuprorelin (leuprolide acetate) | Injection | 3.75 mg | |
| methotrexate | Solution for injection | 25 mg/ ml | |
| methotrexate | Tablet | 2.5 mg | |
| miltefosine | Capsule | 10 mg | |
| miltefosine | Capsule | 50 mg | |
| mycophenolate | Tablet | 180 mg | |
| mycophenolate mofetil | Tablet | 500 mg | |
| mycophenolate sodium | Tablet | 360 mg | |
| natalizumab | Solution for injection | 20 mg/ ml | |
| peginterferon alfa | Solution for injection | 180 uG | |
| peginterferon alfa 2b | Powder for injection | 118.4 mcg/ ml | |
| peginterferon alfa 2b | Powder for injection | 148 mcg/ ml | |
| peginterferon alfa 2b | Powder for injection | 177.6 mcg/ ml | |
| rituximab | Solution for injection | 10 mg/ ml | |
| secuquinumabe | Powder for injection | 150 mg/ ml | |
| sirolimus | Oral liquid | 1mg/ml | |
| sirolimus | Tablet | 1mg | |
| sirolimus | Tablet | 2 mg | |
| tacrolimus | Capsule | 1 mg | |
| tacrolimus | Capsule | 5 mg | |
| tacrolimus | Injection | 5 mg/mL | |
| talidomida | Tablet | 100 mg | |
| teriflunomida | Tablet | 14 mg | |
| tocilizumab | Solution for injection | 20 mg/ ml | |
| tofacitinibe | Tablet | 5 mg | |
| triptorelin | Powder for injection | 11.25 mg | |
| triptorelin | Powder for injection | 3.75 mg | |
| ustekinumab | Solution for injection | 45 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alendronic acid | Tablet | 10 mg | |
| alendronic acid | Tablet | 70 mg | |
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| botulinum toxin A | Powder for injection | 100 U | |
| botulinum toxin A | Powder for injection | 500 U | |
| ibuprofen | Oral suspension | 50 mg/ ml | |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 300 mg | |
| ibuprofen | Tablet | 600 mg | |
| naproxen | Tablet | 250 mg | |
| naproxen | Tablet | 500 mg | |
| pamidronate disodium | Solution for injection | 30 mg | |
| pamidronate disodium | Solution for injection | 60 mg | |
| penicillamine | Capsule | 250 mg | |
| risedronic acid | Tablet | 35 mg | |
| risedronic acid | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Capsule | 250 mg | |
| acetylsalicylic acid | Tablet | 500 mg | |
| amantadine | Tablet | 100 mg | |
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 75 mg | |
| biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
| biperiden | Tablet | 2 mg (hydrochloride) | |
| biperiden | Tablet | 4mg (chlorohydrate) | |
| bromocriptine mesylate | Tablet | 2.5 mg | |
| bupivacaine | Solution for injection | 2.5 mg/ ml | |
| bupivacaine | Solution for injection | 5 mg/ ml | |
| bupropiona clorhidrato | Tablet (prolonged release) | 150 mg | |
| carbamazepine | Oral liquid | 20 mg/ml | |
| carbamazepine | Tablet | 200 mg | |
| carbamazepine | Tablet | 400mg | |
| chlorpromazine | Injection | 5 mg/mL | |
| chlorpromazine | Oral solution (drops) | 40 mg (hydrochloride)/mL | |
| chlorpromazine | Tablet | 100 mg (hydrochloride) | |
| chlorpromazine | Tablet | 25 mg (hydrochloride) | |
| clobazam | Tablet | 10 mg. | |
| clobazam | Tablet | 20 mg | |
| clomipramine | Tablet | 10 mg | |
| clomipramine | Tablet | 25 mg | |
| clonazepam | Oral liquid | 2.5 mg/ml | |
| clozapine | Tablet | 100mg | |
| clozapine | Tablet | 25mg | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Tablet | 10 mg | |
| diazepam | Tablet | 5 mg | |
| dimetilfumarato | Capsule | 120 mg | |
| dimetilfumarato | Capsule | 240 mg | |
| dipyrone | Oral solution | 500 mg/ ml | |
| dipyrone (metamizole sodium) | Injection | 500 mg/ml | |
| dipyrone (metamizole sodium) | Tablet | 500 mg | |
| donepezil hcl | Tablet | 10 mg | |
| donepezil hcl | Tablet | 5 mg | |
| entacapona | Tablet | 200 mg | |
| etosuximida | Syrup | 50 mg/ ml | |
| fluoxetine | Capsule | 20 mg | |
| fluoxetine | Tablet | 20 mg | |
| gabapentin | Capsule | 300 mg. | |
| gabapentin | Capsule | 400 mg | |
| galantamine film coated | Capsule | 16 mg | |
| galantamine film coated | Capsule | 24 mg | |
| galantamine film coated | Capsule | 8 mg | |
| haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
| haloperidol | Injection | 50 mg (as decanoate)/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 1 mg | |
| haloperidol | Tablet | 5 mg | |
| lamotrigine | Tablet | 100 mg | |
| lamotrigine | Tablet | 25 mg | |
| lamotrigine | Tablet | 50 mg | |
| levetiracetam | Oral solution | 100 mg/ ml | |
| levetiracetam | Tablet | 250 mg | |
| levetiracetam | Tablet | 750 mg | |
| levodopa + benserazide | Capsule | 100 mg/ 25 mg | |
| levodopa + benserazide | Tablet | 100 mg/ 25 mg | |
| levodopa + benserazide | Tablet | 200 mg + 50 mg | |
| levodopa + carbidopa | Tablet | 200 mg/ 50 mg | |
| levodopa + carbidopa | Tablet | 250 mg + 25 mg | |
| lidocaine | spray | 100 mg/ ml | |
| lidocaine + epinephrine (adrenaline) | Injection | 1% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial | |
| lidocaine + epinephrine (adrenaline) | Injection | 2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial | |
| lidocaine + epinephrine (adrenaline) | Solution for injection | 2% 1:80.000 | |
| lidocaine + glicose | Solution for injection | 50 mg/ml / 75 mg/ml | |
| lithium carbonate | Tablet | 300 mg | |
| memantina | Tablet | 10 mg | |
| methadone | Injection | 10 mg/ml | |
| methadone | Tablet | 10mg | |
| methadone | Tablet | 5mg | |
| midazolam | Oral liquid | 2 mg/ml | |
| morphine | Injection | 10 mg/ml | |
| morphine | Oral solution | 10 mg/ ml - 60 ml | |
| morphine | Tablet | 10 mg - 200 mg (morphine sulfate) | |
| morphine | Tablet | 30 mg (sulfate) | |
| morphine | Tablet (prolonged release) | 100 mg (morphine sulfate) | |
| morphine | Tablet (prolonged release) | 30 mg (morphine sulfate) | |
| morphine | Tablet (prolonged release) | 60 mg (morphine sulfate) | |
| nicotine replacement therapy (NRT) | Chewing gum | 2 mg (as polacrilex) | |
| nicotine replacement therapy (NRT) | Tablet | 2 mg | |
| nicotine replacement therapy (NRT) | Transdermal patches | 14 mg | |
| nicotine replacement therapy (NRT) | Transdermal patches | 21 mg | |
| nicotine replacement therapy (NRT) | Transdermal patches | 7 mg | |
| nortriptilina | Capsule | 10 mg | |
| nortriptilina | Capsule | 25 mg | |
| nortriptilina | Capsule | 50 mg | |
| nortriptilina | Capsule | 75 mg | |
| nusinersena | Solution for injection | 2,4 mg/ ml | |
| olanzapine | Tablet | 10 mg | |
| olanzapine | Tablet | 5 mg | |
| paracetamol | Oral solution | 200 mg/ ml | |
| paracetamol | Tablet | 500 mg | |
| phenobarbital | Oral solution | 40 mg/ ml | |
| phenobarbital | Tablet | 100 mg | |
| phenobarbitone | Injection | 100 mg/mL | |
| phenytoin | Injection | 50 mg/mL | |
| phenytoin | Oral suspension | 20 mg/ ml | |
| phenytoin | Tablet | 100 mg | |
| pramipexol | Tablet | 0.125 mg | |
| pramipexol | Tablet | 0.25 mg | |
| pramipexol | Tablet | 1 mg | |
| prilocaina + felipresina | Solution for injection | 30 mg/ ml | |
| primidone | Tablet | 100 mg | |
| primidone | Tablet | 250 mg | |
| pyridostigmine | Tablet | 60 mg (bromide) | |
| quetiapine | Tablet | 100 mg (fumarate) | |
| quetiapine | Tablet | 200 mg (fumarate) | |
| quetiapine | Tablet | 25 mg (fumarate) | |
| quetiapine | Tablet | 300 mg (fumarate) | |
| rasagilina | Tablet | 1 mg | |
| riluzol | Tablet | 50 mg | |
| risperidone | Solution | 1 mg/ml | |
| risperidone | Tablet | 1mg | |
| risperidone | Tablet | 2mg | |
| risperidone | Tablet | 3mg | |
| rivastigmina | Capsule | 1.5 mg | |
| rivastigmina | Capsule | 3 mg | |
| rivastigmina | Capsule | 4.5 mg | |
| rivastigmina | Capsule | 6 mg | |
| rivastigmina | Oral solution | 20 mg/ml | |
| rivastigmina | Patch | 18 mg | |
| rivastigmina | Patch | 9 mg | |
| selegiline | Tablet | 10 mg | |
| selegiline | Tablet | 5mg | |
| tafamidis | Capsule | 20 mg | |
| tolcapona | Tablet | 100 mg | |
| topiramate | Tablet | 100 mg | |
| topiramate | Tablet | 25 mg | |
| topiramate | Tablet | 50 mg | |
| trihexyphenidyl | Tablet | 5 mg (hydrochloride) | |
| valproic acid (sodium valproate) | Oral solution | 50 mg/ ml | |
| valproic acid (sodium valproate) | Syrup | 50 mg/ml | |
| valproic acid (sodium valproate) | Tablet | 250 mg | |
| valproic acid (sodium valproate) | Tablet | 500 mg | |
| vigabatrin | Tablet | 500 mg | |
| ziprasidone | Capsule | 40 mg | |
| ziprasidone | Capsule | 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Oral suspension | 40 mg/ ml | |
| albendazole | Tablet (chewable) | 400 mg | |
| artemether + lumefantrine | Tablet | 20 mg + 120 mg | |
| artesunate | Powder for injection | 60 mg | |
| artesunate + mefloquine | Tablet | 100 mg + 220 mg | |
| artesunate + mefloquine | Tablet | 25mg; 55mg | |
| benznidazole | Tablet | 100 mg | |
| benznidazole | Tablet | 12,5 mg | |
| benzoilmetronidazol | Oral suspension | 40 mg/ ml | |
| chloroquine | Tablet | 150mg (phosphate) | |
| diethylcarbamazine | Tablet | 50 mg (dihydrogen citrate) | |
| hydroxychloroquine | Tablet | 400 mg | |
| ivermectin | Tablet | 6 mg | |
| meglumine antimoniate | Injection | 300mg/ml | |
| oxamniquine | Oral suspension | 50 mg/ ml | |
| pentamidine | Powder for injection | 300 mg (isetionate) in ampoule | |
| permethrin | Lotion | 10 mg/ g | |
| permethrin | Lotion | 50 mg/ g | |
| pirimetamine | Tablet | 25 mg | |
| praziquantel | Tablet | 600 mg | |
| primaquine | Tablet | 15 mg (as diphosphate) | |
| primaquine | Tablet | 5 mg (phosphate) | |
| quinine | Injection | 300 mg (dihydrochloride) | |
| quinine | Tablet | 500 mg | |
| teclozan | Oral suspension | 10 mg/ ml | |
| teclozan | Tablet | 500mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alfaporactanto | Suspension for intratracheal instillation | 80 mg/ ml | |
| beclometasone | Capsula para inhalación | 200 mcg/ dose | |
| beclometasone | Capsula para inhalación | 400 mcg/ dose | |
| beclometasone | Powder for inhalacion | 200 mcg/ dose | |
| beclometasone | Powder for inhalacion | 400 mcg/ dose | |
| beclometasone | Solution for inhalation | 200 mcg/ dose | |
| beclometasone | Solution for inhalation | 250 mcg/ dose | |
| beclometasone | Solution for inhalation | 50 mcg/ dose | |
| beclometasone | Suspension para inhalacion nasal | 50 mcg/ dose | |
| beractant | Solution for intratracheal administration | 25 mg/ ml | |
| budesonide | Capsula para inhalación | 200 mcg | |
| budesonide | Capsula para inhalación | 400 mcg | |
| budesonide | Inhalation (aerosol) | 200 mcg | |
| budesonide | Inhalation (aerosol) | 200 micrograms per dose | |
| budesonide | Nasal spray | 32 mg/ds (120 DS) | |
| budesonide | suspension aerosol | 50 mcg | |
| budesonide | suspension aerosol | 64 mcg | |
| budesonide + formoterol | Capsula para inhalación | 12 mcg/ 400 mcg | |
| budesonide + formoterol | Capsula para inhalación | 6 mcg/ 200 mcg | |
| budesonide + formoterol | Powder for inhalacion | 12 mcg/ 400 mcg | |
| budesonide + formoterol | Powder for inhalacion | 6 mcg / 200 mcg | |
| chloruro de sodio | Solution nasal | 0.9 % (9 mg/ ml) | |
| codeine | Injection | 30mg (phosphate)/ml | |
| codeine | Oral solution | 3 mg/ ml | |
| codeine | Tablet | 30 mg (phosphate) | |
| codeine | Tablet | 60mg (phosphate) | |
| dexchlorpheniramine maleate | Oral solution | 0.4 mg/ ml | |
| dexchlorpheniramine maleate | Syrup | 0.4 mg/ ml | |
| dexchlorpheniramine maleate | Tablet | 2 mg | |
| dornase alpha | Solution for inhalation | 1 mg/ ml | |
| fenoterol | Aerosol suspension | 100 mcg/ dose | |
| formoterol fumarate | Capsula para inhalación | 12 mcg | |
| formoterol fumarate | Inhalation (aerosol) | 12 mcg | |
| ipratropium bromide | Solution for inhalation | 0.25 mg/ ml | |
| ipratropium bromide | Solution for inhalation | 20 mcg/ dose | |
| loratadine | Syrup | 1 mg/ ml | |
| loratadine | Tablet | 10 mg | |
| promethazine | Injection | 25mg (hydrochloride)/ml | |
| promethazine | Tablet | 25 mg | |
| salbutamol | Injection | 0.5 mg/mL | |
| salbutamol | Metered dose inhaler (aerosol) | 100 mcg (as sulfate) per dose | |
| salbutamol | Solution for inhalation | 5 mg/ml | |
| salmeterol | Aerosol | 50 mcg | |
| salmeterol | Powder for inhalacion | 50 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| bimatoprost | Solution (eye drops) | 0.3 mg/ ml | |
| brimonidine | Solution (eye drops) | 2 mg/ml | |
| brinzolamide | Suspension | 10 mg/ ml | |
| dexamethasone | Cream | 1 mg/ g (0.1 %) | |
| dexamethasone | Suspension | 1 mg/ ml | |
| dorzolamide | Solution (eye drops) | 20mg/ml | |
| gentamicin | Ointment | 5 mg/ g | |
| gentamicin | Solution (eye drops) | 5 mg/ ml | |
| hypromellose | Solution (eye drops) | 0.3% | |
| hypromellose | Solution (eye drops) | 0.5% | |
| latanoprost | Solution (eye drops) | 0.05 mg/ ml | |
| pilocarpine | Solution (eye drops) | 20 mg/ ml | |
| sulfato de polimixina B + sulfato de neomicina + fluocinolona acetonida + cloridrato de lidocaína | Solution otologica | 10.000 ui/ml + 3,500 mg/ ml + 0,250 mg/ ml + 20 mg/ml | |
| tetracycline | Eye ointment | 10 mg (hydrochloride)/g | |
| timolol | Solution (eye drops) | 0.25% (maleate) | |
| timolol | Solution (eye drops) | 0.5% (maleate) | |
| travoprost | Solution | 0.004% x 2.5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| agua inyectable | Solution for injection | 10 ml | |
| agua inyectable | Solution for injection | 100 ml | |
| agua inyectable | Solution for injection | 5 ml | |
| agua inyectable | Solution for injection | 500 ml | |
| deferasirox | Tablet | 125 mg | |
| deferasirox | Tablet | 250 mg | |
| deferasirox | Tablet | 500 mg | |
| deferiprone | Tablet | 500 mg | |
| desferrioxamine mesilate | Injection | 500 mg | |
| flumazenil | Injection | 0.1 mg/ml | |
| folinic acid | Tablet | 15 mg | |
| fórmula nutricional elemental hipoalergénica a base de aminoácidos. | N/A | N/A | |
| fórmula nutricional elemental hipoalergénica a base de aminoácidos. | N/A | N/A | |
| glicose | Solution for injection | 100 mg/ ml | |
| glicose | Solution for injection | 50 mg/ ml | |
| glicose | Solution for injection | 500 mg/ml | |
| hydroxocobalamin | Powder for injection | 5 g | |
| micronutrients | Powder | vitamina A 400 mcg, vitamina D 5 mcg, vitamina E 5 mg, vitamina C 30 mg, vitamina B1 0,5 mg, vitamina B2 0,5 mg, vitamina B6 0,5 mg, vitamina PP 6 mg, vitamina B9 150 mcg, vitamina B12 0,9 mcg, ferro 10 mg, zinco 4,1 mg, cobre 560 mcg, selênio 17 mcg, iod | |
| naloxone | Injection | 0.4 mg/mL | |
| pralidoxime | Injection | 200 mg/ml | |
| protamine sulfate | Injection | 10 mg/mL | |
| sevelamer carbonate | Tablet | 800 mg |